Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Sep 1.
Published in final edited form as: Nat Chem. 2024 May 20;16(9):1539–1545. doi: 10.1038/s41557-024-01539-4

Discovery of N–X anomeric amides as electrophilic halogenation reagents

Yu Wang 1, Cheng Bi 1, Yu Kawamata 1, Lauren N Grant 2, Lacey Samp 3, Paul F Richardson 4, Shasha Zhang 2, Kaid C Harper 5, Maximilian D Palkowitz 6, Aristidis Vasilopoulos 7, Michael R Collins 4, Martins S Oderinde 8, Chet C Tyrol 9, Doris Chen 4, Erik A LaChapelle 9, Jake B Bailey 10, Jennifer X Qiao 6, Phil S Baran 1,*
PMCID: PMC11457727  NIHMSID: NIHMS2023863  PMID: 38769366

Abstract

Electrophilic halogenation is a widely-used tool employed by medicinal chemists to either pre-functionalize molecules for further diversity or incorporate a halogen atom in drugs or drug-like compounds to solve metabolic problems or modulate off-target effects. Current methods to increase the power of halogenation rely either on the invention of new reagents or activating commercially available reagents with various additives such as Lewis/Brønsted acids, Lewis bases and hydrogen bonding activators. There is a high demand for new reagents that can halogenate otherwise unreactive compounds under mild conditions. Herein we report the invention of a class of powerful halogenating reagents based on anomeric amides, taking advantage of the energy stored in the pyramidalized nitrogen of N–X anomeric amides as a driving force. These robust halogenating methods are compatible with a variety of functional groups and heterocycles, as exemplified on over 50 compounds (including 13 gram-scale examples and 1 flow chemistry scale-up).


Generally speaking, chlorine and bromine atoms are amongst the only functional groups that can be viewed as both facile precursors (gateways) to other functionality (through cross-coupling1) and potentially useful for their inclusion in a final drug substance23. Indeed, numerous FDA approved drugs contain these halogen atoms, and their introduction can often have a documented “magical” effect on desired properties4. For instance (Figure 1A, top), the potency of lead structures 15 and 26 could be improved by several orders of magnitude by the simple installation of chlorine and bromine atoms, respectively. Electrophilic aromatic halogenation7 is arguably the earliest example of industrial practitioners embracing the now wildly popular strategies of “late-stage functionalization”811 and C–H functionalization1213. In fact, recent reviews point to electrophilic halogenation as being one of the reaction classes most prized by medicinal chemists1415. Numerous elegant approaches relying on C–H activation1617 or indirect halogenation1821 via intermediate species, as well as enzymatic halogenation2224 have emerged to provide alternative tactics to access halogenated arenes. That said, there are numerous contexts for which the available reaction and reagent toolkit are insufficient to satisfy demand such as the halogenation of the simple triazole found in vericonazole (3, Figure 1A, bottom). Historical approaches to increase the power of electrophilic halogenation are summarized in Figure 1B and generally rely either on the invention of new reagents2527 or by activating known reagents with additives2833. The majority of electrophilic halogenation reagents are based on stable N-X bonds wherein the flanking substituents on nitrogen include various electron withdrawing groups. Anomeric amides (Figure 1C), introduced by Glover34 and widely studied in the 1980’s have historically been utilized as nitrenium ion precursors via nucleophilic attack at nitrogen3536. In contrast, there have been no investigations we are aware of wherein these unusual species have been harnessed to activate a halogen atom. The premise of this study was that enhanced reactivity might result from the use of reagents based on an anomeric amide by virtue of a spring-loaded driving force to rehybridize following halogenation from a sp3 to sp2 nitrogen center. In this disclosure (Figure 1D), a class of powerful electrophilic reagents based on anomeric amides is presented. Through extensive benchmarking with state-of-the-art protocols, it is shown that such reagents are extremely useful for achieving scalable (in batch and flow settings) and efficient arenes chlorination and bromination at both an early and late stage. Their halogenating power is not limited to arenes as advantages are observed with other reaction manifolds; a computational study supports the defining role of the anomeric amide motif.

Figure 1. Electrophilic halogenation is a useful C-H functionalization tool, state-of-the-art and design of reagents based on anomeric amide.

Figure 1.

a, Cl and Br atoms play an essential role in drug discovery arena, however, electrophilic arene halogenation is challenging in complex contexts, as exemplified by the halogenation of the simple triazole in vericonazole (3); b, Historical approaches to enhance electrophilic halogenation reactivity. Top: selected halogenating reagents. Bottom: commonly used Lewis/Brønsted, Lewis base and hydrogen bonding activation modes; c, Well-precedented usage of anomeric amides as nitrenium ion precursors and our design of it as powerful halogenating reagents, which harnesses the power of the pyramidalized nitrogen; d, This work: practical synthesis of anomeric amide halogenating reagents 6 and 7 and their applications in (hetero)arenes chlorination and bromination. AcOH, acetic acid; TFA, trifluoroacetic acid; HFIP, hexafluoroisopropanol; DMSO, dimethylsulfoxide.

Results and discussion

Very little precedent exists for the synthesis of anomeric amide halogenating agents such as 6 and 7 (Figure 1D). Studies commenced from the known compound 5, constructed using a modified procedure37 that avoids chromatographic purification on decagram scale. In order to access chlorinating reagent 6, tBuOCl was employed as it proceeded in quantitative yield and simplified subsequent purification (filtration). Related systems had been chlorinated before using TCCA38 which was deliberately avoided for practical reasons. In the case of brominating reagent 7, a AgOAc-mediated procedure using Br2 was employed39 followed by recrystallization. Although reagents 6 and 7 are bench-stable solids prepared through scalable and practical procedures, they were stored below 0°C to minimize gradual decomposition, and less than 3% decomposition of 6 and 7 was observed when they were stored under −20 °C for half a year.

With abundant quantities of 6 and 7 in hand, their halogenating potential was explored on the antifungal agent voriconazole (3), a substrate identified as being particularly difficult to halogenate under a variety of conditions (Table 1). Indeed, 23 different chlorinating and brominating reagents/conditions were explored (see Supplementary Table S1 for full conditions). A small selection of the most potent of these combinations are depicted with the highest yields ranging from 27–36%. In these optimal known conditions, the yields were determined by NMR; many of these reactions produced a number of other impurities aside from recovered starting material. In contrast, reagents 6 and 7 cleanly provided the desired chlorinated (3-Cl, 52% isolated) and brominated (3-Br, 79% isolated) products respectively, along with recovered starting material without the use of exotic solvents or acidic additives. The optimal conditions (generally 0.1 to 0.15 M in CH3CN at room temperature − 60 °C, 1 – 40 h) were arrived upon after extensive screening (see Supplementary Table S2 for solvent effect). A reaction-condition-based sensitivity assessment showed that the chlorination reaction is insensitive to variation of reaction parameters (see Supplementary Table S3 for details)40. Notably, unlike many other halogenating agents and conditions, the reaction workup is extremely simple involving only solvent removal followed by purification with no aqueous wash needed. A number of other anomeric amide derivatives were also explored (Table 1) by varying the N- and O-substituents however no improvement was observed. Increasing the steric hindrance around either atom substantially decreased reactivity. Finally, considering that the starting material (4-nitrobenzoyl chloride) for preparing 6 is less expensive than 4-cyanobenzoyl chloride for making 8, 6 was chosen as the optimal chlorinating reagent.

Table 1.

Demonstration of the electrophilic halogenation reactivity of anomeric amides (6 – 12).

graphic file with name nihms-2023863-t0004.jpg

A survey of anomeric halogenating reagents 6 and 7 with precedented halogenation methods/reagents on 3 reveals their superior reactivity, without the use of any additives. Using triazole 3 as the model substrate, other anomeric amide derivatives (812) are also synthesized by varying the N- and O-substituents to investigate substituent effect on chlorination reactivity, however, no improvement was observed.

a

110 °C instead of 60 °C;

b

room temperature.

NCS, N-chlorosuccinimide; DCDMH, 1,3-dichloro-5,5-dimethylhydantoin; TCCA, trichloroisocyanuric acid; TfOH, trifluoromethanesulfonic acid; NBS, N-bromosuccinimide; DBDMH, 1,3-dibromo-5,5-dimethylhydantoin; m-NBSA, m-nitrobenzenesulfonic acid.

With optimized reagents and conditions in hand for halogenation, a broad screen of both building blocks and pharmaceutically relevant substances was pursued as illustrated in Table 2. In most cases, a dramatic increase in yield was observed for chlorination and bromination relative to either literature results or comparison to in-house results using Palau’chlor or NBS. Thus, heterocycles such as 1,2,4-triazoles (13, 14, 33), pyridine (15, 22), pyrazoles (16, 26), indazole (17), thiazole (18, 24), quinoline (2728, 42), pyrimidine (2931), thiophene (36), imidazole (43), others (19, 25) as well as multisubstituted phenyl rings (20, 35, 40, 46) can all be cleanly halogenated.

Table 2.

Selected Scope of Electrophilic Halogenation of Arenes and Heteroarenesa (see Supplementary Table S8 for additional substrates).

graphic file with name nihms-2023863-t0005.jpg
a

Conditions: for chlorination: reagent 6 or Palau’chlor (1.2 – 2.4 equiv), CH3CN (0.1 – 0.15 M), rt – 60 °C, 1 – 40 h; for bromination: reagent 7 (1.2 – 2.4 equiv), CH3CN (0.1 – 0.15 M), rt – 60 °C, 1 – 40 h; or NBS (1.2 – 2.4 equiv), AcOH (0.1 – 0.15 M), rt – 60 °C, 1 – 40 h; for reagents 6 and 7, yields refer to isolated yields; for Palau’chlor and NBS, yields refer to 1H NMR yield using CH2Br2 as internal standard; note: for substrates with a poor solubility in CH3CN, DMF was used instead;

b

room temperature for 24 h then 70 °C for 20 h;

c

Palau’chlor (5.0 equiv), 70 °C, 7 days;

d

48 h;

e

CH3CN/DMF (4:1, v/v) as solvent;

f

DMF as solvent;

g

CHCl3 as solvent;

h

0.05 M;

i

CH3NO2 as solvent;

j

AcOH as solvent;

k

CH3CN/DMF (2:1, v/v) as solvent.

DMF, N,N-dimethylformamide.

Generally, the position-selectivity for halogenation was in accord with what one would normally predict41, although 14 out of the 41 examples favored different sites (see Supplementary Table S4 for predicted halogenation sites). In some cases, such as 20, 44, and 46, the halogenation regioselectivity using 6/7 can be dramatically improved relative to known protocols. Anomeric amide halogenating reagents also exhibit exquisite chemoselectivity relative to the state-of-the-art. For instance, attempted chlorination of celecoxib (26) using Palau’chlor furnished only sulfonamide N-chlorination rather than the desired chloropyrazole product which was exclusively observed using reagent 6 (93% yield on gram-scale). When the simple indazole building block 17 was exposed to Palau’chlor (1.2 equiv, rt, 24 h), ca. 50% conversion to the N-Cl adduct was observed. Subsequent heating at 70 °C for 20 h delivered 47% of 17-Cl, 24% recovered 17, and 27% of dichlorinated 17 (NMR yield). In contrast, using reagent 6 (1.2 equiv, rt, 24 h), a 91% isolated yield of the desired product 17-Cl was observed. In the case of pesticide 42, reagent 7 delivered 42-Br in 47% isolated yield whereas treatment with NBS/AcOH led to 6% desired product (NMR yield) along with a variety of unidentified products. Similarly, the tertiary-alcohol containing antifungal agent 33 could be brominated in 58% isolated yield. In contrast, exposure to NBS (in DMF or AcOH) led to 10–14% of 33-Br (NMR yield) along with extensive decomposition (20–65% of 33 could be recovered). When thiazole 18 was exposed to excess Palau’chlor (5.0 equiv, 70 °C, 7 days), 14% 18-Cl along with 70% 18 was observed, while using reagent 6 (1.6 equiv, 50 °C, 40 h) delivered 44% 18-Cl as well as 50% recovered starting material 18.

The ability to cleanly halogenate at the end of a synthetic route could have benefits in a medicinal chemistry program. For example, structures 2742, 3043, and 3444 have only been previously prepared through early-stage chlorine introduction (see Supplementary Scheme S2 for a summary). Anomeric amide reagents can give those in a drug discovery program optionality, enabling chlorination of end-stage products. In the specific case of rivaroxaban (34), reagent 6 is uniquely successful for this late-stage chlorination relative to Palau’chlor.

Halogenation using 6/7 can be easily performed on gram-scale in batch, with 13 such examples shown in Table 2. Sulfonamides, amides, amines, tertiary alcohols, α-CF3-alcohols, 1,2-aminoalcohols, acetals, and cyclopropanes are all compatible functional groups. The current limitations of this method are not surprising with alkene, alkyne, and sulfoxide-containing substrates being incompatible. Arenes which are too electron-deficient are recalcitrant to halogenation (see Supplementary Table S6 for examples of this). Although attempts toward a catalytic chlorination reaction failed, we found that byproduct 5 of chlorination could be recycled in high yield (see Supplementary Table S7 for experimental details).

Preliminary explorations also point to the enhanced reactivity of anomeric amide reagents in settings other than electrophilic aromatic substitution (Figure 2A). For instance, in the α-bromination of (hetero)aromatic methyl ketones (4749), superior selectivity for mono-bromination is observed across the board. Similarly, the acidic methylene group of cyclic N-sulfonylimine 50 could be efficiently brominated with a superior yield (83%) compared with known procedure (24%) using PyHBr349. An improved yield was also observed in the allylic bromination of (R)-carvone (51) relative to standard conditions5051. Finally, enol acetate 52 (prasugrel) could be chlorinated in nearly quantitative yield.

Figure 2. Application of 6 and 7 in other reactivity modes and flow chemistry.

Figure 2.

a, Explorations of various reactivities other than (hetero)arene electrophilic halogenation; b, Large-scale reaction enabled by continuous flow technology using celecoxib analogue (53) as model substrate. BPO, benzoyl peroxide.

The most glaring concern a practitioner would have in considering the use of anomeric amides such as 6 and 7 is safety on scale. This potential issue was studied extensively (see Supplementary section 11 for experimental data). Since differential scanning calorimetry (DSC) showed both compounds 6 and 7 had decomposition energies above the Yoshida correlation for predicting shock sensitivity and explosive propagation, an internal explosivity test was carried out using modified accelerating rate calorimetry-type equipment equipped with a fast rate data card and pressure transducer. The tests recorded pressure rise rates below the instrument’s calibrated threshold, hence were thought to be negative for potential explosivity52. UN Dangerous Goods Test 3a (ii) BAM Fall Hammer impact testing of 6 and 7 at 60J resulted in decomposition, producing a change in both materials’ color and odor without flame or explosion. The decomposition observed may be due to the impact test generating enough heat to reach each material’s low thermal onset at 79 °C and 84 °C, respectively, to catalyze their exothermic decomposition. During the many gram-scale batch runs using 6 and 7 (vide supra) no hazardous events were observed. However, in order to preemptively address potential concerns on scale, reagent 6 was tested on even larger scale using a flow setup (Figure 2B). Thus, chlorination of celecoxib analogue (53) was pursued in flow at 20 gram-scale. A separate substrate specific optimization was pursued in order to increase the reaction rate and subsequent potential throughput of the reaction. The reaction rate was sensitive to both temperature and solvent composition where the conditions shown in Figure 2B were found to provide >95% conversion in 25 minutes. From these optimized conditions a flow experiment was designed wherein 20 grams of 53 were converted to the desired product over 130 minutes in flow with 82% isolated yield. Observations from the lab-scale demonstration in flow determined that the reaction could be further scaled with minimal consideration.

Finally, the initial hypothesis that halogenating agents based upon an anomeric amide backbone would exhibit superior reactivity was evaluated computationally (Figure 3). Although anomeric amide chlorinating reagent 6 and Palau’chlor have the same N-Cl bond length (both 1.73 Å, longer than 1.66 Å for TCCA53 and 1.69 Å for NCS54), the conversion of 14 to 14-Cl is calculated to be more energetically favorable by 3.4 kcal/mol in terms of ΔΔG using 6 (Figure 3A), which is in accord with experimental findings.

Figure 3. DFT calculation based mechanistic studya.

Figure 3.

a, Higher reactivity of 6 than Palau’chlor is consistent with a more downhill ΔG; b, Calculated N-Cl disassociation energy indicates a weaker N-Cl bond in reagent 6, C-N bond shortening is observed during this process. aCalculation was performed at M06–2x/def2qzvp level.

To gain deeper insight into this higher reactivity, DFT calculations of the N-Cl bond breaking energy (from the ground state to the corresponding anion and Cl+) for both reagents was performed. Calculations indicate that this bond breaking event is significantly uphill for both reagents, but reagent 6 requires 22.0 kcal/mol less energy for bond breaking than Palau’chlor, which means 6 has a more active N-Cl bond (Figure 3B). In the case of reagent 6, when the Cl atom has departed from the N atom, rehybridization at N from sp3 to sp2 occurs and the C-N bond shortens from 1.43 Å (1.42 Å according to X-ray structure) to 1.32 Å., indicating a large energy release during this process. Attempts to determine the ΔΔG if the conjugate anion were to maintain sp3 character failed as it immediately “fell” into the sp2 sink. Thus, the driving force is too exothermic for it to remain sp3-hybridized. Given these results, and since the nitrogen of an anomeric amide such as 6 is well-known to adopt a pyramidal configuration, the additional driving force of 6 (compared to Palau’chlor) is attributed to the additional energy released as a result of conjugation between the N-lone pair and the carbonyl group, a structural feature that is absent in Palau’chlor (or any other known halogenation agent for that matter). In addition, kinetic studies using 15 and roflumilast 35 as model substrates were performed, demonstrating that the chlorination reaction has first-order dependences of both substrate and reagent 6 (see Supplementary Section 10 for detail).

Conclusions

Anomeric amides have been known and extensively studied for over 40 years. This work points to the use for halogenated variants (Cl and Br) of such structures that can take advantage of embedded hybridization/strain that is restored/released when those halogen atoms depart. The resulting reagents demonstrate high reactivity, regio-, and chemoselectivity in challenging electrophilic aromatic halogenations when even the most powerful conditions currently known are low yielding or unfeasible. The safety profile of these structures was studied and numerous gram-scale batch reactions and a decagram flow reaction in mock process setting were demonstrated. Preliminary findings suggest these reagents can have utility in other halogenation reactions as well. Computational studies support the initial hypothesis and may serve as a foundation for the development of other versatile reagents and uses of anomeric amide scaffolds in synthesis.

Methods

General procedure for chlorination and bromination of (hetero)arenes using reagent 6 and 7

To a solution of the substrate (0.1 mmol) in CH3CN (0.1 – 0.15 M) was added the halogenation reagent 6/7 (1.2 equiv) portionwise in 10 min at room temperature (at this point the lights in the vicinity of the apparatus should be turned off and the reaction was protected from direct light irradiation), the reaction mixture was stirred at room temperature − 60 °C for 1 – 24 h. The process of the reaction was monitored by TLC and LC-MS (chlorinated or brominated product is usually less polar than starting material). If there is still some starting material left, another portion of halogenation reagent 6/7 (0.2 – 1.2 equiv) was added again depending on how much starting material was left. After stirred for another 3 – 16 h, solvent was directly removed, and the crude mixture was purified by chromatography on silica gel to provide the desired halogenated product.

Supplementary Material

SI

Acknowledgements

Financial support for this work was provided by the National Institutes of Health (grant number GM-118176, P.S.B.). We thank Dr. D.-H. Huang and Dr. L. Pasternack (Scripps Research) for assistance with NMR spectroscopy; Dr. M. A. Schmidt (BMS) for insightful discussion on computational studies; Dr. M. Gembicky, and Dr. E. Samolova (UCSD) for X-ray crystallographic analysis; Dr. J. Chen, Ms. B. Sanchez, and Ms. Q. N. Wong (Scripps Research ASF) for HRMS.

Footnotes

Competing interests

The authors declare no competing interests.

Data Availability

The data supporting the findings of this study are available within the article and its Supplementary Information. Crystallographic data for the structures reported in this article have been deposited at the Cambridge Crystallographic Data Centre, under the deposition numbers CCDC 2270492 (5), 2238041 (6), 2252734 (7), 2247860 (16-Cl), 2287564 (28-Cl), 2252735 (34-Cl), 2263724 (38-Cl), 2255203 (39-Cl), 2287572 (3-Br), 2263723 (23-Br), 2257302 (25-Br), 2261009 (38-Br), 2278375 (39-Br), 2261010 (43-Br). Copies of the data can be obtained free of charge via https://www.ccdc.cam.ac.uk/structures/.

References

  • (1).Campeau L-C; Hazari N Cross-Coupling and Related Reactions: Connecting Past Success to the Development of New Reactions for the Future. Organometallics 2019, 38, 3–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Smith BR; Eastman CM; Njardarson JT Beyond C, H, O, and N! Analysis of the Elemental Composition of U.S. FDA Approved Drug Architectures. J. Med. Chem. 2014, 57, 9764–9773. [DOI] [PubMed] [Google Scholar]
  • (3).Hernandes MZ; Cavalcanti SM; Moreira DR; de Azevedo Junior WF; Leite AC Halogen atoms in the modern medicinal chemistry: hints for the drug design. Curr. Drug Targets 2010, 11, 303–314. [DOI] [PubMed] [Google Scholar]
  • (4).Chiodi D; Ishihara Y “Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery. J. Med. Chem. 2023, 66, 5305–5331. [DOI] [PubMed] [Google Scholar]
  • (5).Curtin ML; Robin Heyman H; Frey RR; Marcotte PA; Glaser KB; Jankowski JR; Magoc TJ; Albert DH; Olson AM; Reuter DR; Bouska JJ; Montgomery DA; Palma JP; Donawho CK; Stewart KD; Tse C; Michaelides MR Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases. Bioorg. Med. Chem. Lett. 2012, 22, 4750–4755. [DOI] [PubMed] [Google Scholar]
  • (6).Chong P; Sebahar P; Youngman M; Garrido D; Zhang H; Stewart EL; Nolte RT; Wang L; Ferris RG; Edelstein M; Weaver K; Mathis A; Peat A Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. J. Med. Chem. 2012, 55, 10601–10619. [DOI] [PubMed] [Google Scholar]
  • (7).Taylor R; Electrophilic Aromatic Substitution, Wiley, New York, 1990. [Google Scholar]
  • (8).Guillemard L; Kaplaneris N; Ackermann L; Johansson MJ Late-stage C–H functionalization offers new opportunities in drug discovery. Nat. Rev. Chem. 2021, 5, 522–545. [DOI] [PubMed] [Google Scholar]
  • (9).Cernak T; Dykstra KD; Tyagarajan S; Vachal P; Krska SW The medicinal chemist’s toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 2016, 45, 546–576. [DOI] [PubMed] [Google Scholar]
  • (10).Moir M; Danon JJ; Reekie TA; Kassiou M An overview of late-stage functionalization in today’s drug discovery. Expert Opin. Drug Discov. 2019, 14, 1137–1149. [DOI] [PubMed] [Google Scholar]
  • (11).Börgel J; Ritter T Late-Stage Functionalization. Chem 2020, 6, 1877–1887. [Google Scholar]
  • (12).Gutekunst WR; Baran PS C–H functionalization logic in total synthesis. Chem. Soc. Rev. 2011, 40, 1976–1991. [DOI] [PubMed] [Google Scholar]
  • (13).Yamaguchi J; Yamaguchi AD; Itami K C-H Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals. Angew. Chem. Int. Ed. 2012, 51, 8960–9009. [DOI] [PubMed] [Google Scholar]
  • (14).Brown DG; Boström J Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? J. Med. Chem. 2016, 59, 4443–4458. [DOI] [PubMed] [Google Scholar]
  • (15).Roughley SD; Jordan AM The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates. J. Med. Chem 2011, 54, 3451–3479. [DOI] [PubMed] [Google Scholar]
  • (16).Chen X; Hao X-S; Goodhue CE; Yu J-Q Cu(II)-Catalyzed Functionalizations of Aryl C–H Bonds Using O2 as an Oxidant. J. Am. Chem. Soc. 2006, 128, 6790–6791. [DOI] [PubMed] [Google Scholar]
  • (17).Das R; Kapur M Transition-Metal-Catalyzed Site-Selective C–H Halogenation Reactions. Asian J. Org. Chem. 2018, 7, 1524–1541. [Google Scholar]
  • (18).Murphy JM; Liao X; Hartwig JF Meta Halogenation of 1,3-Disubstituted Arenes via Iridium-Catalyzed Arene Borylation. J. Am. Chem. Soc. 2007, 129, 15434–15435. [DOI] [PubMed] [Google Scholar]
  • (19).Boyle BT; Levy JN; de Lescure L; Paton RS; McNally A Halogenation of the 3-position of pyridines through Zincke imine intermediates. Science 2022, 378, 773–779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Cao H; Cheng Q; Studer A Radical and ionic meta-C-H functionalization of pyridines, quinolines, and isoquinolines. Science 2022, 378, 779–785. [DOI] [PubMed] [Google Scholar]
  • (21).Ni S; Yan J; Tewari S; Reijerse EJ; Ritter T; Cornella J Nickel Meets Aryl Thianthrenium Salts: Ni(I)-Catalyzed Halogenation of Arenes. J. Am. Chem. Soc. 2023, 145, 9988–9993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (22).Latham J; Brandenburger E; Shepherd SA; Menon BRK; Micklefield J Development of Halogenase Enzymes for Use in Synthesis. Chem. Rev. 2018, 118, 232–269. [DOI] [PubMed] [Google Scholar]
  • (23).Höfler GT; But A; Hollmann F Haloperoxidases as catalysts in organic synthesis. Org. Biomol. Chem. 2019, 17, 9267–9274. [DOI] [PubMed] [Google Scholar]
  • (24).Crowe C; Molyneux S; Sharma SV; Zhang Y; Gkotsi DS; Connaris H; Goss RJM Halogenases: a palette of emerging opportunities for synthetic biology–synthetic chemistry and C–H functionalisation. Chem. Soc. Rev. 2021, 50, 9443–9481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (25).Attanasi OA; Berretta S; Favi G; Filippone P; Mele G; Moscatelli G; Saladino R Tetrabromo Hydrogenated Cardanol: Efficient and Renewable Brominating Agent. Org. Lett. 2006, 8, 4291–4293. [DOI] [PubMed] [Google Scholar]
  • (26).Rodriguez RA; Pan C-M; Yabe Y; Kawamata Y; Eastgate MD; Baran PS Palau’chlor: A Practical and Reactive Chlorinating Reagent. J. Am. Chem. Soc. 2014, 136, 6908–6911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).Lu Z; Li Q; Tang M; Jiang P; Zheng H; Yang X CFBSA: a novel and practical chlorinating reagent. Chem. Commun. 2015, 51, 14852–14855. [DOI] [PubMed] [Google Scholar]
  • (28).Zhang Y; Shibatomi K; Yamamoto H Lewis Acid Catalyzed Highly Selective Halogenation of Aromatic Compounds. Synlett 2005, 2005, 2837–2842. [Google Scholar]
  • (29).Mo F; Yan JM; Qiu D; Li F; Zhang Y; Wang J Gold-Catalyzed Halogenation of Aromatics by N-Halosuccinimides. Angew. Chem. Int. Ed. 2010, 49, 2028–2032. [DOI] [PubMed] [Google Scholar]
  • (30).Wang W; Yang X; Dai R; Yan Z; Wei J; Dou X; Qiu X; Zhang H; Wang C; Liu Y; Song S; Jiao N Catalytic Electrophilic Halogenation of Arenes with Electron-Withdrawing Substituents. J. Am. Chem. Soc. 2022, 144, 13415–13425. [DOI] [PubMed] [Google Scholar]
  • (31).Maddox SM; Nalbandian CJ; Smith DE; Gustafson JL A Practical Lewis Base Catalyzed Electrophilic Chlorination of Arenes and Heterocycles. Org. Lett. 2015, 17, 1042–1045. [DOI] [PubMed] [Google Scholar]
  • (32).Samanta RC; Yamamoto H Selective Halogenation Using an Aniline Catalyst. Chem. Eur. J. 2015, 21, 11976–11979. [DOI] [PubMed] [Google Scholar]
  • (33).Song S; Li X; Wei J; Wang W; Zhang Y; Ai L; Zhu Y; Shi X; Zhang X; Jiao N DMSO-catalysed late-stage chlorination of (hetero)arenes. Nat. Catal. 2020, 3, 107–115. [Google Scholar]
  • (34).Gerdes RG; Glover SA; ten Have JF; Rowbottom CA N-acetoxy-N-alkoxyamides - a new class of nitrenium ion precursors which are mutagenic. Tetrahedron Lett. 1989, 30, 2649–2652. [Google Scholar]
  • (35).Glover SA Anomeric amides — Structure, properties and reactivity. Tetrahedron 1998, 54, 7229–7271. [Google Scholar]
  • (36).Kennedy SH; Dherange BD; Berger KJ; Levin MD Skeletal editing through direct nitrogen deletion of secondary amines. Nature 2021, 593, 223–227. [DOI] [PubMed] [Google Scholar]
  • (37).Qi T; Fang N; Huang W; Chen J; Luo Y; Xia Y Iron(II)-Catalyzed Nitrene Transfer Reaction of Sulfoxides with N-Acyloxyamides. Org. Lett. 2022, 24, 5674–5678. [DOI] [PubMed] [Google Scholar]
  • (38).Sutton AD; Williamson M; Weismiller H; Toscano JP Optimization of HNO Production from N,O-bis-Acylated Hydroxylamine Derivatives. Org. Lett. 2012, 14, 472–475. [DOI] [PubMed] [Google Scholar]
  • (39).Beebe TR; Wolfe JW N-bromination of amides, imides, and sulfonamides with acetyl hypobromite. J. Org. Chem. 1970, 35, 2056–2057. [Google Scholar]
  • (40).Pitzer L; Schäfers F; Glorius F Rapid Assessment of the Reaction-Condition-Based Sensitivity of Chemical Transformations. Angew. Chem., Int. Ed. 2019, 58, 8572–8576. [DOI] [PubMed] [Google Scholar]
  • (41).Kruszyk M; Jessing M; Kristensen JL; Jørgensen M Computational Methods to Predict the Regioselectivity of Electrophilic Aromatic Substitution Reactions of Heteroaromatic Systems. J. Org. Chem. 2016, 81, 5128–5134. [DOI] [PubMed] [Google Scholar]
  • (42).Korganow A-S; Eftekhari P; Wagner A; Baehr C Analogues of hydroxychloroquine (HCQ) without retinal toxicity. US 201906227878 A1, February 28, 2019. [Google Scholar]
  • (43).Regnier G; Canevari RJ; Laubie MJ; Le Douarec JC Synthesis and vasodilator activity of new piperazine derivatives. J. Med. Chem. 1968, 11, 1151–1155. [DOI] [PubMed] [Google Scholar]
  • (44).Rohrig S Substituted oxazolidinones and the use thereof. US 20100184767 A1, July 22, 2010. [Google Scholar]
  • (45).Beatty JW; Lindsey EA; Thomas-Tran R; Debien L; Mandal D; Jeffrey JL; Tran AT; Fournier J; Jacob SD; Yan X; Drew SL; Ginn E; Chen A; Pham AT; Zhao S; Jin L; Young SW; Walker NP; Leleti MR; Moschütz S; Sträter N; Powers JP; Lawson KV Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73. J. Med. Chem. 2020, 63, 3935–3955. [DOI] [PubMed] [Google Scholar]
  • (46).Baloniak S; Katresiak A Synthesis and Reactivity of some 1,2,4-Triazolo[4,3-b]pyridazine Derivatives. Polish J. Chem. 1994, 68, 683–691. [Google Scholar]
  • (47).Chen C-M; Chen J-X; To CT Solvent-free mechanochemical chlorination of pyrazoles with trichloroisocyanuric acid. Green Chem. 2023, 25, 2559–2562. [Google Scholar]
  • (48).Krake EF; Baumann W Selective Oxidation of Clopidogrel by Peroxymonosulfate (PMS) and Sodium Halide (NaX) System: An NMR Study. Molecules 2021, 26, 5921–5932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (49).Esumi N; Suzuki K; Nishimoto Y; Yasuda M Generation of α-Iminyl Radicals from α-Bromo Cyclic N-Sulfonylimines and Appliction to Coupling with Various Radical Acceptors Using a Photoredox Catalyst. Chem. Eur. J. 2018, 24, 312–316. [DOI] [PubMed] [Google Scholar]
  • (50).Kim C-S; Morisawa J; Nishiyama N; Kashiwagi T; Tebayashi S.-i.; Horiike M. Determination of the Absolute Configuration of (+)-2,7(14),10-Bisabolatrien-1-ol-4-one from Japanese Cedar, Cryptomeria japonica. Biosci. Biotechnol. Biochem. 2002, 66, 1997–2000. [DOI] [PubMed] [Google Scholar]
  • (51).Kobayashi K; Kunimura R; Takagi H; Hirai M; Kogen H; Hirota H; Kuroda C Total Synthesis of Highly Oxygenated Bisabolane Sesquiterpene Isolated from Ligularia lankongensis: Relative and Absolute Configurations of the Natural Product. J. Org. Chem. 2018, 83, 703–715. [DOI] [PubMed] [Google Scholar]
  • (52).Bodman GT; Chervin S Use of ARC in Screening for Explosive Properties. J. Hazard. Mater. 2004, 115, 101–105. [DOI] [PubMed] [Google Scholar]
  • (53).Bilke M; Losch P; Vozniuk O; Bodach A; Schüth F Methane to Chloromethane by Mechanochemical Activation: A Selective Radical Pathway. J. Am. Chem. Soc. 2019, 141, 11212–11218. [DOI] [PubMed] [Google Scholar]
  • (54).Brown RN The crystal structure of N-chlorosuccinimide. Acta Cryst. 1961, 14, 711–715. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

Data Availability Statement

The data supporting the findings of this study are available within the article and its Supplementary Information. Crystallographic data for the structures reported in this article have been deposited at the Cambridge Crystallographic Data Centre, under the deposition numbers CCDC 2270492 (5), 2238041 (6), 2252734 (7), 2247860 (16-Cl), 2287564 (28-Cl), 2252735 (34-Cl), 2263724 (38-Cl), 2255203 (39-Cl), 2287572 (3-Br), 2263723 (23-Br), 2257302 (25-Br), 2261009 (38-Br), 2278375 (39-Br), 2261010 (43-Br). Copies of the data can be obtained free of charge via https://www.ccdc.cam.ac.uk/structures/.

RESOURCES